CDC Director resigns over tobacco stock scandal
January 31, 2018Medical Communications Brenda Fitzgerald, CDC, US, pharma
Dr Brenda Fitzgerald, the Director of the Centers for Disease Control and Prevention, the United States’ leading national public health …
Ipsen promotes new CMO from within
January 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, ipsen, pharma, pharmaceutical
Ipsen has announced that Sotirios G. Stergiopoulos will become its newest Chief Medical Officer, performing the role alongside his current …
UK charity Breast Cancer Care receives £655,000 cash injection to expand end-of-treatment app
January 31, 2018Research and Development Breast Cancer Care, National lottery, UK, breast cancer, charity, pharma
UK charity Breast Cancer Care (BCC) is set to expand the development of its end-of-treatment support app after receiving a …
NHS Digital lambasted for collusion with Home Office to deport migrants
January 31, 2018Medical Communications, Research and Development NHS Digital, biotech, drugs, immigration, pharma, pharmaceutical
NHS Digital, the Department of Health and the Home Office have been strongly criticised for entering a memorandum of understanding …
Pfizer teams up with Indian Government to battle antimicrobial resistance
January 31, 2018Medical Communications, Research and Development India, Pfizer, antimicrobial resistance, pharma
Pfizer has entered into a partnership with the Indian Council of Medical Research (ICMR) in an effort to fight antimicrobial …
Amazon makes first steps into healthcare, alongside big partners
January 31, 2018Medical Communications, Research and Development Berkshire Hathaway, JPMorgan, amazon, biotech, drugs, pharma, pharmaceutical
Amazon’s move into the healthcare sector has been widely mooted over the last 12 months and it officially announced that …
Italy refuses to give up hope on EMA HQ
January 30, 2018Medical Communications, Research and Development EMA, amsterdam, biotech, drugs, pharma, pharmaceutical
It is no secret that Milan was not best pleased that it was pipped to the post to host the …
Read Pharmafocus January/February 2018 edition online now!
January 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Ablynx, Alex Azr, Celgene, Pharmafocus, Sanofi, UK, artificial intelligence, bioverativ, brexit, juno therapeutics, multiple myeloma, serialisation
With the holiday period a distant memory by now, Pharmafocus is back with its January/febraury edition. It’s hard to imagine …
Philippines’ Department of Health demands full refund of $70m Dengvaxia programme from Sanofi
January 30, 2018Manufacturing and Production, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma
In the latest development in Sanofi’s Philippines dengue vaccine scandal, the nation’s Department of Health has demanded that the French …
Apotex President resigns amidst Founder’s murder and allegations of accepting Teva secrets
January 30, 2018Manufacturing and Production, Medical Communications Apotex, Jeremy Desai, Teva, pharma
Following the alleged murder of its founder Barry Sherman and his wife in December last year, Canada’s largest generic drug …
Celgene Executive Chairman Bob Hugin to retire
January 30, 2018Manufacturing and Production, Medical Communications Bob Hugin, Celgene, pharma
Fresh from its acquisition of Juno Therapeutics, Celgene has announced that its Executive Chairman Bob Hurgin is to retire effective …
FDA revises methods, after public outrage at testing of monkeys
January 29, 2018Manufacturing and Production, Medical Communications FDA, biotech, drugs, pharma, pharmaceutical
The story broke in September of last year that the FDA was testing nicotine addiction in squirrel monkeys and that …
Santhera’s Raxone rejected in Europe for Duchenne muscular dystrophy
January 29, 2018Sales and Marketing Duchenne Muscular Dystrophy, EMA, Europe Santhera, pharma
While the EMA’s Committee for Medicinal products for Human Use (CHMP) recommended a spree of treatments over the past week, …
Delivering the life sciences agenda: Easy as ABC
January 29, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life sciences strategy, biotech, brexit, drugs, pharma, pharmaceutical
Andrew Blevins and Andrew Carrington of Liberty Property Trust and Countryside Properties explain how organisations at the Cambridge Biomedical Campus …
Radioactive drug given approval by the FDA
January 29, 2018Sales and Marketing Advanced Accelerator Applications, Lutathera, Novartis, biotech, drugs, pharma, pharmaceutical
The FDA has approved Lutathera, marking the first time that the agency has given approval for a radioactive drug or …
EMA committee recommends seven therapies from Roche, GSK, MSD and more
January 29, 2018Sales and Marketing Biocon, Chiesi, Chugai, GSK, GlaxoSmithKline, MSD, Mylan, Roche, Sanofi, pharma
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has voiced its recommendation of a raft of …
Brexit Health Alliance warns of UK at back of the medicine queue
January 29, 2018Medical Communications, Sales and Marketing biotech, brexit, drugs, pharma, pharmaceutical
The Brexit Health Alliance (BHA) has cautioned that unless a favourable deal is struck, the UK could end Brexit negotiations …
Sanofi swoops for Ablynx in $4.8bn deal
January 29, 2018Sales and Marketing Ablynx, Sanofi, biotech, drugs, pharma, pharmaceutical
Sanofi has moved quickly to tie up a deal with Ablynx for $4.8 billion, when it looked more likely that …
Top Ten most popular articles on Pharmafile.com this week
January 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abcam, Alzheimer's, Dr Reddy's, GSK, J&J, JJ, Reckitt Benckiser, Remicade, Sanofi, influenza, opioid crisis, opioids, top ten, valproate
As we come to the end of January, it’s Friday again – time for another rundown of the top ten …
NICE urges curbing the use of antibiotics for sore throats
January 26, 2018Medical Communications Antibiotics, NICE, biotech, drugs, pharma, pharmaceutical
In a study published by the BMJ a few years ago, it was found that antibiotics were prescribed in 60% …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
